Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
De-novo mutations
100%
Hyperinflammation
100%
Hemophagocytic
100%
Dipeptidyl Peptidase 9
100%
Inflammasome Activation
57%
Inflammasome
57%
Autoinflammation
42%
HEK293 Cells
28%
NLRP1
28%
Pancytopenia
28%
CARD8
28%
Triglycerides
14%
Natural Killer Cells
14%
Genetic Analysis
14%
Increased Vulnerability
14%
Susceptibility to Infection
14%
Serum Levels
14%
Negative Regulator
14%
Gain-of-function mutation
14%
Interleukin-1β
14%
Patient Cells
14%
Lactate Dehydrogenase
14%
Induced Pluripotent Stem Cells (iPSCs)
14%
Neutrophils
14%
Genetic Causes
14%
Inborn Errors of Immunity
14%
Genetic Defects
14%
Dominant Negative
14%
Amino Acid Residues
14%
Ferritin
14%
Hemophagocytic Lymphohistiocytosis
14%
Molecular Investigation
14%
Genetic Investigation
14%
Interleukin-18 (IL-18)
14%
Skin Manifestations
14%
Soluble interleukin-2 Receptor (sIL-2R)
14%
Model Cell
14%
Conserved Amino Acids
14%
Elevated Levels
14%
Biallelic Loss
14%
Immunology and Microbiology
Inflammasome
100%
NLRP1
25%
Infancy
25%
Infectious Disease
12%
Natural Killer Cell
12%
Primary Immunodeficiency
12%
Interleukin 2
12%
Blood Level
12%
Neutrophil
12%
Induced Pluripotent Stem Cell
12%
Interleukin 1
12%
Loss of Function Mutation
12%
Hemophagocytic Lymphohistiocytosis
12%
Genetic Background
12%
Interleukin 18
12%
Amino Acid
12%
Infection
12%
Susceptibility
12%
Lactic Acid
12%
Lactate
12%
Ferritin
12%